Table 4.

Comparison of the serum AMH and LH/FSH ratio between the three subgroups of the PCOS patients.

	ANOVA		Multiple comparisons
	F value	P value	Subgroups	Mean ± Sd.	p value
AMH (ng/mL)	3.38	0.04	T	7.23 ± 3.61	0.039 (vs non-T)
			Non-T	5.86 ± 3.98	0.746 (vs non-HA)
			Non-HA	5.73 ± 3.82	0.045 (vs T)
LH/FSH	0.47	0.63	T	1.82 ± 1.28	0.962 (vs non-T)
			Non-T	1.83 ± 1.39	0.396 (vs non-HA)
			Non-HA	1.57 ± 1.86	0.356 (vs T)

T subgroup (hyperandrogenemia (HA) with T elevated), non-T subgroup (HA with other androgens elevated but T, such as A2, DHT, DHEA or DHEAS), non-HA subgroup (no androgen elevated). A one-way analysis of variance (ANOVA), followed by a LSD (Least Significant Difference) test, was used in comparison among three groups.